Hydration to protect kidneys after atrial fibrillation ablation
Part of Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests if giving extra fluids before, during, and after a new type of heart procedure (pulsed field ablation) can prevent kidney injury. If you have atrial fibrillation and are scheduled for this ablation, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have symptomatic atrial fibrillation that comes and goes (paroxysmal) or is persistent (lasting more than 7 days but less than a year).
- You have tried at least one heart rhythm medication (like flecainide or amiodarone) and it didn't work well or you couldn't take it.
- You are scheduled to receive pulsed field ablation for your atrial fibrillation.
- You are willing to come back for check-ups at 30 and 90 days after the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer ablation technique called pulsed field ablation to treat atrial fibrillation, a heart rhythm disorder. The goal is to see if this method works well and is safe for patients who need treatment.
This study investigates whether a catheter ablation procedure can improve wellbeing and reduce the risk of serious events for people 80 and older with symptomatic atrial fibrillation. The goal is to see if this treatment offers better outcomes than standard care in this age group.
This trial tests if acupuncture can help prevent atrial fibrillation (an irregular heart rhythm) from coming back after a procedure called catheter ablation. If you have had ablation and your heart rhythm is back to normal, this study may help you stay in a healthy rhythm.
This trial tests two different ablation techniques to treat a type of irregular heartbeat that doesn't go away on its own. It aims to find which approach works better and is safer.
This study tests a modified 'pills-in-the-pocket' approach—taking antiarrhythmic drugs only when symptoms occur—for people with non-valvular atrial fibrillation (AF) who still have arrhythmias lasting over 24 hours after their first catheter ablation. It aims to see if this strategy can safely control symptoms without needing daily medication.
This trial compares a procedure called ablation (using cold, heat, or electric pulses to fix irregular heartbeats) with standard medications to see which better treats heart failure in people who also have atrial fibrillation. It may help if your heart's pumping ability is reduced and you still have symptoms despite medications.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.